The Protein Myth: Our Obsession With Protein and How It Is Killing US

Houston Methodist

G. Davis

Health of Vegetarians and Vegans: Findings From EPIC-Oxford and Othe…

Physicians Committee for Responsible Medicine

T. J. Key

Advancing Type 2 Diabetes Care with Omnipod® 5

Omnipod®

V. Shah, D. Kruger, T. Ly

Medications for Weight Loss: The New Satiety Hormones

Scripps Health

K. Fujioka

Do Triglycerides Cause Heart Disease?

National Lipid Association

I. Goldberg

GLP-1/GIP Update: Stay Tuned... The Best is Yet to Come!!

Robert Busch

Evidence that Obesity and Diabetes are Driven by a Diet-Induced Biol…

University of Colorado Department of Medicine

R. Johnson

MAFLD: What Is It?

Houston Methodist

D. Victor

Labs to Check on Semaglutide or Tirzepatide

Susan Brian

Tirzepatide Updates

Diana Isaacs

Incretin-based Therapies in the Management of Obesity and its Comorb…

Michigan Medicine

A. Rothberg

Weightloss in Menopause

Susan Brian

The Deadly Paradox: Current Practice, Driven by Guidelines, Is Not A…

Michael Makover

Colchicine: Now and What’s Next?

National Lipid Association

C. Ballantyne

Effects of Low Calorie and Alternative Sweeteners Across the Lifespa…

Keck School of Medicine of USC

M. Goran

Rainbow Lentil Soup: Columbia / IHN Breast Cancer Awareness Culinary…

Columbia University Institute of Human Nutrition

O. Weinstein

Metabolic Surgery vs. Pharmacotherapy for Treatment of Obesity

Practical Ways to Achieve Targets in Diabetes Care

S. Nissen

Discussing Retatrutide: A GIP, GLP-1, and Glucagon Receptor Agonist

Susan Brian

Obesity: New Understanding and Treatments

Norman Lepor

The Differences Between the Products of GLP1's and GLP/GIPs

Susan Brian